AlphaStocks

COLL vs PARR

COLLEGIUM PHARMACEUTICAL, INC vs PAR PACIFIC HOLDINGS, INC. — Side-by-Side Stock Comparison

COLL

COLLEGIUM PHARMACEUTICAL, INC

4.8

Weak

$33.25

PARR

PAR PACIFIC HOLDINGS, INC.

8.8

Strong Buy

$61.66

COLL vs PARR: Which is the Better Investment?

COLLEGIUM PHARMACEUTICAL, INC (COLL) scores 4.8/10 while PAR PACIFIC HOLDINGS, INC. (PARR) scores 8.8/10 on AlphaStocks' composite model. PAR PACIFIC HOLDINGS, INC. has the higher composite rating of Strong Buy. On a P/E basis, PAR PACIFIC HOLDINGS, INC. trades at 8.6x, making it the more attractively priced of the two.

This comparison is algorithmically generated and is not financial advice.

MetricCOLLPARR
Scores & Fundamentals
Composite Score4.8/108.8/10
RatingWeakStrong Buy
Price$33.25$61.66
P/E Ratio21.08.6
ROE10.1%25.4%
Market Cap$1.3T$3B
Fair Value$44.43
Dividend Yield
Sector Rank#629 of 1127#1 of 1127
Model Verdicts
PiotroskiAttractiveStrong
BuffettNeutralStrong
GrahamCautionCaution
LynchNeutralStrong
GreenblattStrongAttractive
View full COLLanalysis →View full PARRanalysis →
Compare any two stocks →

COLL vs PARR: Which Stock Scores Higher?

COLLEGIUM PHARMACEUTICAL, INC (COLL) and PAR PACIFIC HOLDINGS, INC. (PARR) are among the most compared stocks in the S&P 500. PARR currently leads with a composite score of 8.8/10 (Strong Buy) compared to COLL's 4.8/10 (Weak).

The AlphaStocks composite score evaluates each stock across four dimensions: Quality (business strength measured by Piotroski F-Score and Buffett quality criteria), Value (discount to intrinsic worth using Graham, Lynch, and Greenblatt models), Momentum (6-month price trend), and Timing (a confirmation signal that requires both value and momentum to align). A higher composite score indicates stronger overall fundamentals combined with favorable market conditions.

This comparison uses the same scoring framework for both companies, ensuring an apples-to-apples evaluation. Scores are recalculated daily after market close using data from SEC filings and market prices. Read the full methodology to understand how each model contributes to the composite score.

Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer